Know the product
A named product. An individual plan.
01 · Product identityNon-crosslinked HA and succinate formulation
The 1.8% name identifies a particular Xela Rederm formulation. Other concentrations in the range and Electri should not be assumed identical. An ingredient percentage is not a ranking of which treatment is best for an individual patient.
02 · Your priorityDescribe one visible goal.
A useful goal is a clearer description of the dry or finely creased area and how it behaves in daily life. The plan may focus on surface quality rather than changing the outline of the face. Natural pores and small expression changes remain normal.
03 · A complete planAsk about the review.
At review, compare the original dry-looking or finely creased area under similar light. Note comfort and sensitivity as well as appearance. Temporary injection-site changes should settle before judging the cosmetic response, and persistent problems need assessment.